1,777
Participants
Start Date
March 31, 2014
Primary Completion Date
November 30, 2018
Study Completion Date
November 30, 2018
Spironolactone
Placebo
Standard care
Standard diabetes care
Steno Diabets Center Copenhagen, Gentofte Municipality
Instituto de Ricerche Farmacologiche Mario Negri, Bergamo
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Madrid
Universitair Ziekenhuis, Ghent
Institut Klinické a Experimentální Mediciny, Prague
Universita Karlova v Praze, Prague
Universitätsklinikum Carl Gustav Carus, Technischen Universität Dresden, Dresden
Diabetologen Hessen, Hessen
Klinikum St. Georg gGmbH, Leipzig
Geniko Nosikomeico Athinas Ippokrateio, Hospital Diabetes Center, Athens
University Medical Center Groningen, Groningen
Diabetes Vascular Research Foundation, Hoogeveen
Stichting VUMC, Hoorn
Department of Nephrology, University of Skopje, Skopje
University of Glasgow, Glasgow
Collaborators (2)
Mosaiques Diagnostics GmbH
UNKNOWN
University Medical Center Groningen
OTHER
University of Glasgow
OTHER
Istituto Di Ricerche Farmacologiche Mario Negri
OTHER
Univerzita Karlova v Praze
OTHER
Geniko Nosokomeio Athinas Ippokrateio
UNKNOWN
Institut Klinické a Experimentální Mediciny Praze
UNKNOWN
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
OTHER
Klinikum St. Georg Leipzig
UNKNOWN
Cyril and Methodius University in Skopje
UNKNOWN
Hannover Clinical Trial Center
UNKNOWN
European Commission
OTHER
Diabetes Vascular Research Foundation Hoogeveen
UNKNOWN
University Ghent
OTHER
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
UNKNOWN
Stichting VUMC
UNKNOWN
Diabetologen Hessen
UNKNOWN
Peter Rossing
OTHER